BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38452755)

  • 1. Epidemiology and risk factors of bloodstream infections among adolescents and young adults with acute lymphoblastic leukaemia: An 11-year retrospective cohort study.
    Xue L; Tang Y; Wang L; Xu C; Cheng Q; Li X
    Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13850. PubMed ID: 38452755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections.
    Kuo FC; Wang SM; Shen CF; Ma YJ; Ho TS; Chen JS; Cheng CN; Liu CC
    J Microbiol Immunol Infect; 2017 Aug; 50(4):507-513. PubMed ID: 26442676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.
    Ammann RA; Laws HJ; Schrey D; Ehlert K; Moser O; Dilloo D; Bode U; Wawer A; Schrauder A; Cario G; Laengler A; Graf N; Furtwängler R; Simon A
    Eur J Pediatr; 2015 May; 174(5):675-86. PubMed ID: 25804192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction therapy for acute lymphoblastic leukemia: incidence and risk factors for bloodstream infections.
    Silva RAM; de Mendonça RMH; Dos Santos Aguiar S; Yajima JC; Marson FAL; Brandalise SR; Levy CE
    Support Care Cancer; 2022 Jan; 30(1):695-702. PubMed ID: 34363492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.
    Kahn JM; Keegan TH; Tao L; Abrahão R; Bleyer A; Viny AD
    Cancer; 2016 Sep; 122(17):2723-30. PubMed ID: 27286322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
    Matsushima S; Kobayashi R; Sano H; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28763. PubMed ID: 33047887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes.
    Lalayanni C; Demosthenous C; Iskas M; Kelaidi C; Papathanasiou M; Syrigou A; Athanasiadou A; Papalexandri A; Batsis I; Vardi A; Polychronopoulou S; Sakellari I
    Leuk Lymphoma; 2022 Dec; 63(13):3128-3137. PubMed ID: 36002396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
    Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
    McNeer JL; Bleyer A
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26989. PubMed ID: 29418064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999-2014.
    Kontula KSK; Skogberg K; Ollgren J; Järvinen A; Lyytikäinen O
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):945-952. PubMed ID: 29455272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment.
    Janardan SK; Miller TP
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):581-586. PubMed ID: 38066874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis.
    Namjoshi NS; Keegan THM; Li QC; Chung JH; Rosenthal JL; Winestone LE; Muffly L; Malogolowkin MH; Alvarez EM
    Leuk Lymphoma; 2022 Dec; 63(13):3191-3199. PubMed ID: 35999808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
    Liu L; Moke DJ; Tsai KY; Hwang A; Freyer DR; Hamilton AS; Zhang J; Cockburn M; Deapen D
    J Natl Cancer Inst; 2019 May; 111(5):509-518. PubMed ID: 30321398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.
    Choi H; Ahn H; Lee R; Cho SY; Lee DG
    Infect Chemother; 2022 Jun; 54(2):340-352. PubMed ID: 35794719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
    Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
    Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology and Outcomes of Bloodstream Infections in Patients With Solid Tumors in a Central American Population at Mexico Hospital, San Jose, Costa Rica.
    Calvo-Lon J; Landaverde DU; Ramos-Esquivel A; Villalobos-Vindas JM
    J Glob Oncol; 2018 Sep; 4(4):1-6. PubMed ID: 29244630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing
    Handal N; Whitworth J; Lyngbakken MN; Berdal JE; Dalgard O; Bakken Jørgensen S
    Infect Dis (Lond); 2024 Jan; 56(1):19-31. PubMed ID: 37795955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
    Unger JM; Beauchemin M; Hershman DL
    Cancer; 2021 Dec; 127(24):4574-4584. PubMed ID: 34351619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.
    Majhail NS; Brazauskas R; Hassebroek A; Bredeson CN; Hahn T; Hale GA; Horowitz MM; Lazarus HM; Maziarz RT; Wood WA; Parsons SK; Joffe S; Rizzo JD; Lee SJ; Hayes-Lattin BM
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):861-73. PubMed ID: 22040843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.